RANDOMIZED PHASE-II EVALUATION OF IPROPLATIN (CHIP) AND CARBOPLATIN (CBDCA) IN LUNG-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL

被引:25
作者
KRAMER, BS
BIRCH, R
GRECO, A
PRESTRIDGE, K
DESIMONE, P
OMURA, G
机构
[1] UNIV ALABAMA,BIRMINGHAM,AL
[2] UNIV FLORIDA,GAINESVILLE,FL 32611
[3] VANDERBILT UNIV,NASHVILLE,TN 37240
[4] UNIV KENTUCKY,LEXINGTON,KY 40506
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1988年 / 11卷 / 06期
关键词
D O I
10.1097/00000421-198812000-00010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:643 / 645
页数:3
相关论文
共 6 条
[1]  
CANETTA R, 1984, CHEMOTHERAPY F S, V6, P44
[2]  
CHAHINIAN AP, 1985, P AM ASSOC CANC RES, V26, P261
[3]  
KREISMAN H, 1987, CANCER TREAT REP, V71, P1049
[4]  
MONG S, 1980, CANCER RES, V40, P3318
[5]  
OLVER IN, 1986, CANCER TREAT REP, V70, P421
[6]  
ROSE WC, 1985, P AM ASSOC CANC RES, V26, P258